
Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Detailed statistics
Genetic testing market size worldwide 2024-2034
Detailed statistics
Genetic testing market size worldwide 2024-2034
Detailed statistics
Genetic testing market worldwide 2024, by end-use
Detailed statistics
Genetic testing market worldwide 2024, by end-use
Detailed statistics
Willingness to know future cancer risk via genetic testing in the U.S. 2022
Detailed statistics
Willingness to know future cancer risk via genetic testing in the U.S. 2022
Genetic testing market size worldwide 2024-2034
Annual value of the genetic testing market worldwide from 2024 to 2034 (in billion U.S. dollars)
Genetic testing market size worldwide 2024-2034
Annual value of the genetic testing market worldwide from 2024 to 2034 (in billion U.S. dollars)
Genetic testing market worldwide 2024, by end-use
Distribution of the genetic testing market worldwide in 2024, by end-use
Genetic testing market worldwide 2024, by end-use
Distribution of the genetic testing market worldwide in 2024, by end-use
Genetic test average cost used for precision medicine worldwide by region 2022-2027
Average cost of a genetic test used for precision medicine worldwide from 2022 to 2027, by region (in U.S. dollars)
Genetic test average cost used for precision medicine worldwide by region 2022-2027
Average cost of a genetic test used for precision medicine worldwide from 2022 to 2027, by region (in U.S. dollars)
Genetic test average cost used for precision medicine worldwide 2022-2027
Average cost of a genetic test used for precision medicine worldwide from 2022 to 2027 (in U.S. dollars)
Genetic test average cost used for precision medicine worldwide 2022-2027
Average cost of a genetic test used for precision medicine worldwide from 2022 to 2027 (in U.S. dollars)
Number of genetic tests used for precision medicine globally 2022-2027
Total number of genetic tests used for precision medicine worldwide from 2022 to 2027 (in millions)
Number of genetic tests used for precision medicine globally 2022-2027
Total number of genetic tests used for precision medicine worldwide from 2022 to 2027 (in millions)
Share of genetic tests used for precision medicine by world region 2022-2027
Percentage of genetic tests used for precision medicine worldwide from 2022 to 2027, by region
Share of genetic tests used for precision medicine by world region 2022-2027
Percentage of genetic tests used for precision medicine worldwide from 2022 to 2027, by region
Share of genetic tests used for precision medicine globally 2022-2027
Percentage of genetic tests used for precision medicine worldwide from 2022 to 2027
Share of genetic tests used for precision medicine globally 2022-2027
Percentage of genetic tests used for precision medicine worldwide from 2022 to 2027
Most talked-about DNA companies worldwide Q1 2022
Leading DNA companies worldwide between January and March 2022, by number of online impressions
Most talked-about DNA companies worldwide Q1 2022
Leading DNA companies worldwide between January and March 2022, by number of online impressions
23andMe revenue 2021-2024
Revenue of 23andMe from 2021 to 2024 (in million U.S. dollars)
23andMe revenue 2021-2024
Revenue of 23andMe from 2021 to 2024 (in million U.S. dollars)
23andMe net income 2021-2024
Net income of 23andMe from 2021 to 2024 (in million U.S. dollars)
23andMe net income 2021-2024
Net income of 23andMe from 2021 to 2024 (in million U.S. dollars)
Illumina, Inc. revenue 2019-2023
Revenue of Illumina, Inc. from 2019 to 2023 (in billion U.S. dollars)
Illumina, Inc. revenue 2019-2023
Revenue of Illumina, Inc. from 2019 to 2023 (in billion U.S. dollars)
Exact Sciences revenue 2019-2023
Revenue of Exact Sciences from 2019 to 2023 (in million U.S. dollars)
Exact Sciences revenue 2019-2023
Revenue of Exact Sciences from 2019 to 2023 (in million U.S. dollars)
Qiagen revenue 2012-2024
Revenue of Qiagen from 2012 to 2024 (in million U.S. dollars)
Qiagen revenue 2012-2024
Revenue of Qiagen from 2012 to 2024 (in million U.S. dollars)
Guardant Health revenue 2019-2023
Revenue of Guardant Health from 2019 to 2023 (in million U.S. dollars)
Guardant Health revenue 2019-2023
Revenue of Guardant Health from 2019 to 2023 (in million U.S. dollars)
Neogenomics revenue 2019-2023
Revenue of Neogenomics from 2019 to 2023 (in million U.S. dollars)
Neogenomics revenue 2019-2023
Revenue of Neogenomics from 2019 to 2023 (in million U.S. dollars)
Fulgent Genetics revenue 2019-2023
Revenue of Fulgent Genetics from 2019 to 2023 (in million U.S. dollars)
Fulgent Genetics revenue 2019-2023
Revenue of Fulgent Genetics from 2019 to 2023 (in million U.S. dollars)
Invitae revenue 2018-2022
Revenue of Invitae from 2018 to 2022 (in million U.S. dollars)
Invitae revenue 2018-2022
Revenue of Invitae from 2018 to 2022 (in million U.S. dollars)
Willingness to know future cancer risk via genetic testing in the U.S. 2022
Distribution of willingness to know cancer risk via a genetic test in the United States in 2022, by type
Willingness to know future cancer risk via genetic testing in the U.S. 2022
Distribution of willingness to know cancer risk via a genetic test in the United States in 2022, by type
Reasons for taking a genetic test in the U.S. 2022
Reasons adults took a genetic test in the United States as of 2022
Reasons for taking a genetic test in the U.S. 2022
Reasons adults took a genetic test in the United States as of 2022
Confidence in accuracy of genetic testing in the U.S. in 2022
Distribution in confidence of genetic test results in the United States in 2022
Confidence in accuracy of genetic testing in the U.S. in 2022
Distribution in confidence of genetic test results in the United States in 2022
Use of genetic testing in the U.S. in 2022, by type
Share of people who have ever had a genetic test in the United States in 2022, by type
Use of genetic testing in the U.S. in 2022, by type
Share of people who have ever had a genetic test in the United States in 2022, by type
Adults taking a genetic test to share the results with relatives U.S. 2024, by gender
Share of adults who took a genetic test because they want to share the results with relatives in the United States in 2024, by gender
Adults taking a genetic test to share the results with relatives U.S. 2024, by gender
Share of adults who took a genetic test because they want to share the results with relatives in the United States in 2024, by gender
Concerns regarding the impact of genetic testing for cancer risk in the U.S. 2023
Share of people who were concerned the following areas would be impacted by genetic tests to determine cancer risk in the United States in 2023
Concerns regarding the impact of genetic testing for cancer risk in the U.S. 2023
Share of people who were concerned the following areas would be impacted by genetic tests to determine cancer risk in the United States in 2023
Familiarity with genetic testing to determine cancer risk in the U.S. in 2023, by age
Share of people who had heard of genetic testing to determine cancer risk in the United States in 2023, by age
Familiarity with genetic testing to determine cancer risk in the U.S. in 2023, by age
Share of people who had heard of genetic testing to determine cancer risk in the United States in 2023, by age
Awareness of DTC genetic testing companies among health professionals Europe 2022
Awareness of DTC genetic testing companies among health professionals Europe as of 2022
Awareness of DTC genetic testing companies among health professionals Europe 2022
Awareness of DTC genetic testing companies among health professionals Europe as of 2022
Attitudes towards DTC genetic testing among health professionals Europe 2022
Distribution of opinions among health professionals regarding the results of DTC genetic testing in Europe as of 2022
Attitudes towards DTC genetic testing among health professionals Europe 2022
Distribution of opinions among health professionals regarding the results of DTC genetic testing in Europe as of 2022
Belief in regulations on DTC genetic testing among health professionals Europe 2022
Share of health professionals who believed the following aspects DTC genetic testing should be regulated in Europe as of 2022
Belief in regulations on DTC genetic testing among health professionals Europe 2022
Share of health professionals who believed the following aspects DTC genetic testing should be regulated in Europe as of 2022
Behavior changes as a result of genetic testing in the U.S. 2022
Behavior changes as a result of genetic testing in the United States as of 2022
Behavior changes as a result of genetic testing in the U.S. 2022
Behavior changes as a result of genetic testing in the United States as of 2022
Taking a genetic test due to doctor recommendation U.S. 2024, by gender
Share of adults who took a genetic test because of their doctor's recommendation in the United States as of 2024, by gender
Taking a genetic test due to doctor recommendation U.S. 2024, by gender
Share of adults who took a genetic test because of their doctor's recommendation in the United States as of 2024, by gender
Use of genetic tests to make health decisions U.S. 2024, by gender
Share of adults who took a genetic test so that the information would affect their healthcare decisions in the United States in 2024, by gender
Use of genetic tests to make health decisions U.S. 2024, by gender
Share of adults who took a genetic test so that the information would affect their healthcare decisions in the United States in 2024, by gender
Use of genetic testing for cancer risk in the U.S. in 2023, by gender
Share of people who have ever had a genetic test to determine cancer risk in the United States in 2023, by gender
Use of genetic testing for cancer risk in the U.S. in 2023, by gender
Share of people who have ever had a genetic test to determine cancer risk in the United States in 2023, by gender
Use of genetic testing for cancer risk in the U.S. in 2023, by age
Share of people who have ever had a genetic test to determine cancer risk in the United States in 2023, by age
Use of genetic testing for cancer risk in the U.S. in 2023, by age
Share of people who have ever had a genetic test to determine cancer risk in the United States in 2023, by age
National policy/programs of noninvasive prenatal testing in Europe 2020, by country
Adoption of noninvasive prenatal testing (NIPT) in national policy and programs in Europe as of 2020, by country
National policy/programs of noninvasive prenatal testing in Europe 2020, by country
Adoption of noninvasive prenatal testing (NIPT) in national policy and programs in Europe as of 2020, by country
Share of women receiving noninvasive prenatal testing in Europe 2020, by country
Share of pregnant women who received noninvasive prenatal testing (NIPT) in national policy and programs in Europe in 2020, by country
Share of women receiving noninvasive prenatal testing in Europe 2020, by country
Share of pregnant women who received noninvasive prenatal testing (NIPT) in national policy and programs in Europe in 2020, by country
Noninvasive prenatal testing market size in the United States 2023-2033
Annual value of the noninvasive prenatal testing market in the United States from 2023 to 2033 (in billion U.S. dollars)
Noninvasive prenatal testing market size in the United States 2023-2033
Annual value of the noninvasive prenatal testing market in the United States from 2023 to 2033 (in billion U.S. dollars)
Attitudes towards the development of cell and gene therapies in the U.S. 2023
Distribution of attitudes towards the development and commercialization of cell and gene therapies in the past and near future as of 2023
Attitudes towards the development of cell and gene therapies in the U.S. 2023
Distribution of attitudes towards the development and commercialization of cell and gene therapies in the past and near future as of 2023
Commercialization considerations regarding cell and gene therapies in the U.S. 2023
Organizations' considerations regarding commercialization of cell and gene therapies in the United States as of 2023, by organization type
Commercialization considerations regarding cell and gene therapies in the U.S. 2023
Organizations' considerations regarding commercialization of cell and gene therapies in the United States as of 2023, by organization type
Number of active trials for cell and gene therapies worldwide 2022 by trial phase
Number of active trials for cell and gene therapies in the global pipeline as of 2022, by trial phase
Number of active trials for cell and gene therapies worldwide 2022 by trial phase
Number of active trials for cell and gene therapies in the global pipeline as of 2022, by trial phase
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)